# Headway Pulls New Clinician Contracts One Day After Rollout as Therapists Push Back

> Headway paused its new clinician contract rollout one day after sending it, and CEO Andrew Adams told providers he takes responsibility for the terms.

- Published: 2026-10-19T21:27:45+00:00
- Section: Incidents
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-19/headway-retracts-clinician-contracts-backlash
- Source: [Bhbusiness](https://bhbusiness.com/2026/10/19/headway-issues-then-retracts-new-clinician-contracts-after-backlash/)

## Key takeaways

- Headway paused the rollout of a new provider agreement one day after sending it to clinicians on its platform.
- CEO Andrew Adams wrote that the contract was interpreted in ways the company never intended and that he takes responsibility.
- Therapist Jen Bohan ended her Headway contract, with termination effective November 16, after receiving the agreement.

[Headway](https://akta.pro/company-profiles/00000li/headway) retracted a new clinician contract one day after rolling it out to providers on its platform, pausing the rollout in an email from CEO Andrew Adams. The company did not say when revised contracts would be sent. Headway is a New York-based therapist enablement platform founded in 2015 that connects clinicians with insurance-backed clients.

## Headway's Contract Rollout and Reversal

Headway sent the updated provider agreement to clinicians last Thursday with a deadline to review and sign, [Bhbusiness](https://bhbusiness.com/2026/10/19/headway-issues-then-retracts-new-clinician-contracts-after-backlash/) reported. Adams wrote to providers the following day that the company would pause the rollout. "We sent out an updated Provider Agreement yesterday, and a lot of you wrote back, understandably," Adams wrote. "It was very reasonably interpreted in ways we never intended. This isn't our standard, and I take responsibility."

The original document asked 1099-contracted clinicians to agree to several updates, including relinquishing rights over their names, images, voices and content indefinitely without additional payment or prior approval. Providers who opted into Headway's marketplace option, which adds clients at a $9.99 fee per client obtained through that method, were barred from encouraging marketplace-sourced patients to leave Headway during their contract or for one year after. The contract also required clinicians to use Headway's designated documentation templates and platforms rather than third-party tools, and allowed Headway to take back payments if services did not meet billing, documentation or other requirements.

Clinicians who already signed the agreement will have that document nullified and will receive the revised contract along with other providers once it is available. Jen Bohan, owner of Jen Bohan Therapy, told Bhbusiness she ended her contract after receiving it, with termination effective November 16. "This was the straw," Bohan said. "When your values aren't congruent to the actions... particularly in the case with Headway right now, where not only was this sneaky, but then we get an email saying, 'Oh, you misinterpreted this.' That's very gaslighty."

## Headway's Funding and AI Investments

Headway's valuation stands at $2.3 billion, more than double the approximately $1.2 billion of its prior round, according to akta.pro [company records](https://akta.pro/company-data). The company has raised six funding rounds on record, including a $100 million Series D in July 2024 led by Spark Capital and a $125 million Series C in October 2023 led by Spark Capital. In March 2026, Headway acquired the team behind AI company Tezi, integrating co-founder Raghavendra Prabhu as VP of Engineering to lead AI development for patient-provider matching and administrative automation.

## Headway's Recent Marketplace Backlash

Headway announced a new opt-in patient marketplace charging clinicians $9.99 per session in October 2026, sparking backlash from clinicians and industry, Bhbusiness reported. The fee applies only to marketplace patients, not those booked via direct links, and clinicians can opt out. In August 2026, Headway announced the publication of peer-reviewed research in JMIR Mental Health analyzing PHQ-9 responses from 189,225 patients ages 6 to 64 across all 50 states and D.C. between January 2024 and October 2025, PR Newswire reported.

## What Comes Next for Headway Providers

Headway has not disclosed when it may roll out the revised contracts or which portions it will rework. Bohan's contract termination takes effect November 16.

## Companies in this story

- [Headway company profile](https://akta.pro/company-profiles/00000li/headway) · website: https://headway.co

---
News for Agent · https://newsforagent.com/llms.txt